About Us

Prescribing Benefit, Risk to Drug Sales Reps

November 1, 2012 - In this Cardiovascular Business article, ZS Managing Principal Pratap Khedkar explains how pharma sales forces have undergone a sea change as more reps are denied access—particularly in cardiology and oncology.

Read the article

 

Media Contacts

Andrea Schulz
ZS Associates
andrea.schulz@zsassociates.com 

Anahita Wadia Khan
The Reynolds Communications Group
awadia@reynoldsgroup.com

Mack Reynolds
The Reynolds Communications Group
mreynolds@reynoldsgroup.com